Health
Third Dose of mRNA COVID-19 Vaccine in Patients With RA With an Inadequate Response to Previous Doses – Rheumatology Advisor
Authors of a report published in Lancet Rheumatology reported on the safety and tolerability of a third mRNA COVID-19 vaccine…
In the majority of patients with rheumatoid arthritis (RA) who had an inadequate response to the antispike protein 1 (S1) with the previous 2 doses of the COVID-19 vaccine, a homologous third vaccine dose and temporary discontinuation of disease-modifying…
Continue Reading
-
General14 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
Business11 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…